Prognostic factor | Points | No. of patients |
---|---|---|
General condition (performance status) | ||
Poor (PS 10–40%) | 0 | 23 |
Moderate (PS 50–70%) | 1 | 45 |
Good (PS 80–100%) | 2 | 52 |
No. of extraspinal bone metastases | ||
≥ 3 | 0 | 34 |
1–2 | 1 | 25 |
0 | 2 | 61 |
No. of metastases in the vertebral body | ||
≥ 3 | 0 | 63 |
2 | 1 | 20 |
1 | 2 | 37 |
Metastases to the major internal organs | ||
Unremovable | 0 | 21 |
Removable | 1 | 2 |
No metastases | 2 | 97 |
Primary site of cancer | ||
Lung | 0 | 120 |
Palsy | ||
Complete (Frankel A B) | 0 | 5 |
Incomplete (Frankel C D) | 1 | 83 |
None (Frankel E) | 2 | 32 |
Tumor markers | ||
Abnormal | 1 | 79 |
Normal | 2 | 41 |
Adoption of targeted therapy | ||
Without | 1 | 72 |
With | 2 | 48 |
Prognostic groups | Total points | |
Group A | 0–8 | 58 |
Group B | 9–14 | 62 |